Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Iscience|January 2, 2023
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profilesEmma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
Eclinicalmedicine|November 11, 2020
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, EnglandShamez N Ladhani, Anna Jeffery-Smith, Monika Patel, et al.
The Lancet. Haematology|January 29, 2021
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trialAndrés J M Ferreri, Jeanette K Doorduijn, Alessandro Re, et al.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
The Lancet. Haematology|October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Leukemia|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Blood Advances|November 14, 2022
CNL and aCML should be considered as a single entity based on molecular profiles and outcomesGonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Claire Harrison, et al.
Blood|January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Haematologica|May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencingWendy Osborne, Euan Haynes, William Wilson, et al.
Blood|January 6, 2026
Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell LymphomaJuan Pablo Alderuccio, Diva Baggio, Sunwoo Han, et al.
Pageof 8